Other FYX Solutions

C Diff Phase 2 Clinical Trial (C Diff FYX)

COVID 19 proposed treatment (COVID FYX)

The Covid-19 pandemic proved the necessity for a better alternative to the jab. We have floated our oral antibody solution past several Infectious Disease specialists, with positive reaction. Below is our proposal to eliminate Covid-19 and future pandemics, without resorting to discriminatory mandates and soul destroying lockdowns. If you see merit in our technology and would like to help, please contact me directly or consider purchasing our HEALTH FYX Lozenges. Get DefYant, Be Healthy. For Covid-19 it’s all about the antibodies … be it natural antibodies from infection or artificially acquired antibodies as a result of the vaccine. Unfortunately, in either case you never know the level of antibodies you will develop or how long they will last. Our Antibodies come from the Immune System of laying hens, which are harvested from their eggs for a very safe treatment, with no worrisome side effects.

Two main advantages of DefYant Antibodies

"Guaranteed Titre Levels". Contrary to your naturally or vaccine acquired Antibodies, we know exactly the level of COVID Antibodies you will be getting. And we'll also know the amount you'll need to either prevent or eliminate infection.
Targeted placement of Infection Blocking Antibodies in the nose, mouth and gut, where ACE 2 virus receptor cells are located. By blocking infection, we can cancel transmission and eradicate the virus. And with no virus there is no Pandemic and no mandates.

Our proposed COVID treatment will be a nasal/mouth spray of purified antibodies to protect ACE 2 receptors in the nasal cavity and upper respiratory tract, and chewable lozenges to protect ACE 2 receptors in the gut. This treatment would be used to give protection when in contagious environments and to retard internal spread and reduce viral load if already infected.

Initial target will be a treatment for already sick COVID-19 patients. Our orally dosed antibodies will be used as a droplet (nasal spray) to be systemically absorbed through the nasal cavity. We are confident this treatment will help retard internal spread, while reducing viral load to help the patient recover.
A second and more important target is a preventive treatment designed to work like an invisible Biological Mask and block the COVID-19 virus before it enters your body. Something jab vaccines can’t do. And without a host to infect, the virus can be eradicated.

Research has shown the Coronavirus enters your body through specific ACE-2 receptor cells in your nose and gut to start the infection. We’ve been protecting gut cells from infection for 20 years and should be able to use the same purified Antibodies to protect nasal cells as well. When facing a potential contagious situation, you would take 5 oral dose tablets to protect gut cells and a spray in each nostril to protect nasal cells.

Infection Blocking use of egg derived antibodies has been proven in vitro by research published 10/27/21, showing the potential use of egg derived antibodies to block entry of this virus (Egg yolk immunoglobulin (IgY) targeting SARS-CoV-2 S1 as potential virus entry blocker).
Therapeutic use of egg derived antibodies would be similar to that shown in recent research, where breast milk from previously infected or vaccinated mothers can be used to eliminate Long COVID (Case report: human breast milk from vaccinated woman clears persistent SARS-CoV-2 infection).
(Producing COVID-19 antibodies in hen eggs).

There is also evidence COVID-19 patients, who either have had the virus and cleared it from the upper respiratory tract, or had been asymptomatic from the start, can carry the virus in their gut and stool for another 45 days. And these carriers can still transmit the virus to others. Therefore another application of our oral dose gut antibodies could be to prevent this transmission. A final consideration with all medical treatments is safety. Our oral Antibodies are derived from eggs and considered Generally Regarded As Safe (GRAS) by the FDA.

FAQ

Is this scientifically feasible? In layman's terms, Antibodies kill the cause of infections and can kill a pathogen on contact in most environments. Several Infectious Disease specialists agree this could be a viable solution.
Is it safe? Our Antibodies are harvested from eggs, which are Generally Regarded As Safe (GRAS) by the FDA.
Will it work? We have proven oral dose Antibodies are effective, with two registered Veterinary Biologic treatments for animals and an ongoing phase 2 clinical trial of our C Difficile Antibodies for humans. Research published 10/27/21 has shown the viability of the technique in vitro (Egg yolk immunoglobulin (IgY) targeting SARS-CoV-2 S1 as potential virus entry blocker).
Can it be produced in volume? Egg derived Antibodies are the easiest to scale up of all Antibody sources.
Will it be affordable? Egg derived Antibodies are the least costly Antibodies to produce.
Can it be done quickly? We need a vaccine to start the process, which we can do much faster than a human vaccine. After that the first product can be available within 4 months.
Can it be used for future pandemics? Once the platform is shown to work it's a simple matter to change the target. And that target may also eventually include the yearly flu virus.
Would people take the treatment? It will be a simple trial to determine therapeutic and protective efficacy. There are many people who will choose, for whatever reasons, not to take the vaccine. Our preventive treatment will provide a scientifically proven and likely better alternative.
Is there something available now? Nothing yet directly targeting Coronavirus.

For information on how you can participate please contact me directly. John Hare, john@hareman.com 941-221-2505 (USA) 204-955-8495 (Canada)